56 related articles for article (PubMed ID: 19550376)
1. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
[TBL] [Abstract][Full Text] [Related]
3. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs.
Hugon G; Adriaensen H; Wintrebert M; Arnould L; Serfaty JM; Robert P
Invest Radiol; 2024 May; ():. PubMed ID: 38709660
[TBL] [Abstract][Full Text] [Related]
5. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.
Akine Y; Tokita N; Tokuuye K; Satoh M; Churei H; Le Pechoux C; Kobayashi T; Kanda K
Jpn J Cancer Res; 1993 Aug; 84(8):841-3. PubMed ID: 8407547
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of half-dose contrast-enhanced scanning of brain tumours at 5.0 T: a preliminary study.
Jiang Z; Sun W; Xu D; Mei H; Yuan J; Song X; Ma C; Xu H
BMC Med Imaging; 2024 Apr; 24(1):88. PubMed ID: 38615005
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging.
Toprak N; Unal O; Avcu S
Pol J Radiol; 2015; 80():401-10. PubMed ID: 26405464
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
9. Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data.
Endrikat J; Schwenke C; Prince MR
Clin Radiol; 2015 Jul; 70(7):743-51. PubMed ID: 25933719
[TBL] [Abstract][Full Text] [Related]
10. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
11. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.
Anzalone N; Essig M; Lee SK; Dörfler A; Ganslandt O; Combs SE; Picozzi P
Neurosurgery; 2013 May; 72(5):691-701. PubMed ID: 23381488
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of image quality and diagnostic accuracy of 0.5 molar gadobenate dimeglumine and 1.0 molar gadobutrol in contrast-enhanced run-off magnetic resonance angiography of the lower extremities.
Achenbach M; Figiel JH; Burbelko M; Heverhagen JT
J Magn Reson Imaging; 2010 Nov; 32(5):1166-71. PubMed ID: 21031523
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.
Voth M; Michaely HJ; Schwenke C; Vos B; Pietsch H
Eur Radiol; 2011 Feb; 21(2):337-44. PubMed ID: 20809127
[TBL] [Abstract][Full Text] [Related]
15. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.
Kim ES; Chang JH; Choi HS; Kim J; Lee SK
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1055-8. PubMed ID: 20110372
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
[TBL] [Abstract][Full Text] [Related]
18. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
[TBL] [Abstract][Full Text] [Related]
19. Time optimization of gadobutrol-enhanced brain MRI for metastases and primary tumors using a dynamic contrast-enhanced imaging.
Seo J; Lim C; Lee KY; Koh YC; Moon WJ
BMC Med Imaging; 2022 Oct; 22(1):180. PubMed ID: 36253718
[TBL] [Abstract][Full Text] [Related]
20. A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System.
Tanaka A; Masumoto T; Yamada H; Kurauchi M; Breuer J
Magn Reson Med Sci; 2016; 15(2):227-36. PubMed ID: 26687097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
